The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees

The rapid replacement of Omicron BA.1 by BA.2 sublineage is very alarming, raising the question of whether BA.2 can escape the immunity acquired after BA.1 infection. We compared the neutralizing activity toward the Omicron BA.1 and BA.2 sub-lineages in five groups: COVID-19 patients; subjects who h...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, Claudia Semplici, Pietro Piu, Giulia Piccini, Linda Benincasa, Serena Marchi, Emanuele Andreano, Piero Lovreglio, Nicola Buonvino, Nicola Decaro, Angela Stufano, Eleonora Lorusso, Emilio Bombardieri, Antonella Ruello, Simonetta Viviani, Rino Rappuoli, Eleonora Molesti, Alessandro Manenti, Emanuele Montomoli
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2022-11-01
Sarja:	Human Vaccines & Immunotherapeutics
Aiheet:	hybrid immunity mrna booster neutralizing antibodies omicron ba.1 omicron ba.2 sars-cov-2 sars-cov-2 vaccines
Linkit:	http://dx.doi.org/10.1080/21645515.2022.2129196
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!